Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (ASCENT)

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2024
This article has no abstract
Epistemonikos ID: b4a2e55160481136a01d3387a28250e38cea55e2
First added on: Apr 11, 2025